BEKANAMYCIN

SynDRA canonical compound SYN0005926 — structure-anchored drug synonym record

Clinical phase	Launched
Mechanism of action	bacterial 30S ribosomal subunit inhibitor
Indication	gram-negative bacterial infections
Disease area	infectious disease

All known targets

Kanamycin B
aminodeoxykanamycin
kanendomycin
Nebramycin V
Bekanamycine
Bekanamicina
Kanamycin b
Nebramycin v
NK-1006
Aminodeoxykanamycin
nebramycin factor 5
Bekanamycinum
Becanamicina
Bekanamycinum [INN-Latin]
Bekanamycine [INN-French]
Becanamicina [INN-Spanish]
EINECS 225-170-5
BRN 0061646
Aminodeoxykanamycin sulfate
Antibiotic derived from Streptomyces kanamyceticus
AC1L2FQA
AC1Q57UP
Antibiotic derived from Streptomyces kanamyceticus. Kanamycin B
(1r,2s,4r,6s)-4,6-diamino-3-[(3-amino-3-deoxy-
A-d-glucopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-
Bekanamycin [INN]
2'-Amino-2'-deoxykanamycin
Klebcil
15JT14C3GI
CHEBI:28098
Bekanamycin (INN)
(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-(((1R,2S,3S,4R,6S)-4,6-diamino-3-(((2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)tetrahydro-2H-pyran-3,4-diol
(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2S,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4-diol
(1R,2S,3S,4R,6S)-4,6-diamino-3-[(3-amino-3-deoxy-alpha-D-glucopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside
(1R,2S,3S,4R,6S)-4,6-diamino-3-(3-amino-3-deoxy-alpha-D-glucopyranosyloxy)-2-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside
O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1->4)-O-(2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1->6))-2-deoxy-D-streptamine
UNII-15JT14C3GI
NCGC00096063-01